Start Insulin Immediately
A patient with type 1 diabetes must begin insulin therapy immediately upon diagnosis, regardless of whether they feel they "need it yet"—this is a non-negotiable, life-preserving intervention. Type 1 diabetes is characterized by absolute insulin deficiency due to autoimmune destruction of pancreatic beta cells, and insulin is not optional but essential for survival 1.
Why Insulin Cannot Be Delayed
Type 1 diabetes fundamentally differs from type 2 diabetes. In type 1, the body produces little to no insulin, making exogenous insulin replacement mandatory from diagnosis onward. The perception that insulin is "not needed yet" reflects a dangerous misunderstanding of the disease mechanism 1.
Critical Risks of Withholding Insulin
- Diabetic ketoacidosis (DKA): Without insulin, the body cannot utilize glucose and breaks down fat for energy, producing ketones that acidify the blood. This is a medical emergency that can be fatal 2.
- Severe hyperglycemia: Blood glucose levels will rise uncontrollably, leading to acute symptoms (polyuria, polydipsia, weight loss) and long-term complications.
- Metabolic decompensation: The patient may feel "fine" temporarily while beta cell function is declining, but sudden deterioration can occur rapidly.
The "Honeymoon Period" Misconception
Some patients with newly diagnosed type 1 diabetes experience a brief "honeymoon period" where residual beta cell function temporarily reduces insulin requirements. However, this does NOT mean insulin should be stopped 3. Recent literature describes "stage 3a" type 1 diabetes—early stage 3 where some patients might not immediately require insulin—but this represents a small subset and requires careful monitoring 3. Even in this scenario, the goal is close surveillance, not insulin avoidance.
The standard of care remains clear: insulin therapy is initiated at diagnosis of type 1 diabetes 2, 1.
Recommended Insulin Regimen
Based on current guidelines 2:
Initial Approach
- Start basal insulin: 10 units per day OR 0.1-0.2 units/kg per day
- Choose basal analog insulin (preferred over NPH due to more predictable action and lower hypoglycemia risk)
- Set fasting plasma glucose (FPG) goal based on individualized targets (typically 80-130 mg/dL for most adults)
Titration Strategy
- Increase by 2 units every 3 days to reach FPG goal without hypoglycemia
- For hypoglycemia: identify cause; if unclear, reduce dose by 10-20%
- Reassess every 3-6 months and adjust as needed
Progression to Full Regimen
Most adults with type 1 diabetes require multiple daily injections (MDI) of basal-bolus insulin 4, 1:
- Basal insulin once or twice daily
- Rapid-acting prandial insulin before meals (starting with 4 units or 10% of basal dose at largest meal)
- Adjust based on carbohydrate intake, premeal glucose, and anticipated activity
Essential Concurrent Interventions
- Prescribe glucagon for emergency hypoglycemia treatment 2
- Diabetes self-management education and support (DSMES): Teach carbohydrate counting, insulin dosing, glucose monitoring, and hypoglycemia recognition 2, 1
- Continuous glucose monitoring (CGM) or frequent blood glucose monitoring to guide insulin adjustments 4, 1
- Consider insulin pump therapy for those not meeting targets or experiencing frequent hypoglycemia 4
Common Pitfall to Avoid
Do not confuse type 1 diabetes management with type 2 diabetes, where insulin can sometimes be delayed while using oral medications. In type 1 diabetes, there are no oral agents that can substitute for insulin as primary therapy. The 2025 ADA guidelines explicitly state to "consider insulin as the first injectable if...a diagnosis of type 1 diabetes is a possibility" 2.
The patient's belief that she "doesn't need it yet" likely stems from either misunderstanding her diagnosis (possibly has type 2 diabetes instead) or dangerous misinformation about type 1 diabetes management. Verify the diagnosis is truly type 1 diabetes (presence of autoantibodies, low/absent C-peptide), and if confirmed, insulin must be started without delay.